GALNT10 and ovarian serous adenocarcinoma: Altered glycosylation was found to occur in malignancy (Oliveira-Ferrer et al., 2017) and GALNT10 is one of the glycosyltransferases whose expression was associated with poor prognosis in high grade ovarian serous cancer (Zhang et al., 2020b).